| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.4319 | 47 |
| GSM780708 | Untreated after 4 days (C2_1) | 55.1637 | 60 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.6466 | 55 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.5762 | 16 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.4357 | 34 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.8077 | 40 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.1762 | 38 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.2068 | 23 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.3424 | 5 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.6339 | 53 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 41.9035 | 13 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.5599 | 30 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 49.8163 | 48 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.8031 | 36 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.7807 | 16 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 37.7128 | 2 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.6255 | 61 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.7306 | 35 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.1947 | 23 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 53.4926 | 57 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.7106 | 12 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 38.1312 | 3 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.5651 | 35 |